Kaiser Family Foundation September 22, 2022
Juliette Cubanski, Tricia Neuman, Meredith Freed

The Inflation Reduction Act of 2022, signed into law by President Biden on August 16, 2022, includes several provisions to lower prescription drug costs for people with Medicare and reduce drug spending by the federal government. This legislation has taken shape amidst strong bipartisan, public support for the government to address high and rising drug prices. CBO estimates that the drug pricing provisions in the reconciliation bill will reduce the federal deficit by $237 billion over 10 years (2022-2031).

The prescription drug proposals included in the Inflation Reduction Act will:

Today's Sponsors

LEK
Teladoc Health
Amwell

Today's Sponsors

LEK
Teladoc Health

Today's Sponsor

Oliver Wyman

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech, Regulations
Lokavant raises $21M for clinical trial data platform
Industry Voices—The growing role of pharmacists in driving down drug costs through transparency
How a new investment is powering a revolution in clinical trial operations
How Virtual-First Clinical Trials Scale Access for Participants
We must improve diversity in clinical trials. These 5 steps will help.